In hospitals, infectious disease specialists help ensure the timely diagnosis and treatment of acute infections by recommending the appropriate diagnostic tests to identify the source of the infection and by recommending the appropriate antibiotic to treat the infection.
Biochemical tests used in the identification of infectious agents include the detection of metabolic or enzymatic products characteristic of a particular infectious agent. Since bacteria ferment carbohydrates in patterns characteristic of their genus and species, the detection of fermentation products is commonly used in bacterial identification. Acids, alcohols and gases are usually detected in these tests when bacteria are grown in selective liquid or solid media.

Market Analysis and Insights: Global Infectious Disease Testing Market
The global Infectious Disease Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Infectious Disease Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Infectious Disease Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Infectious Disease Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Infectious Disease Testing market.

Global Infectious Disease Testing Scope and Market Size
Infectious Disease Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Infectious Disease Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Technology and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Technology
Immunodiagnostics
Clinical Microbiology
PCR
INAAT
DNA Sequencing & NGS
DNA Microarrays
Other

Segment by Application
Hospitals/Clinical Laboratories
Reference Laboratories
Academic/Research Institutes
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott Diagnostics
Abbott
Beckman Coulter Diagnostics
Roche
Siemens Healthcare
Abaxis
Acon Laboratories
Avioq
BD
Bio-Rad Laboratories
Cavidi
Cepheid
Chembio Diagnostic Systems
Clarity Diagnostics
EMD Millipore
Epitope Diagnostic
Gold Standard Diagnostics
Hologic
Immunetics
InBios International
Life Technologies
Maxim Biomedical